iNeuMab™ Rat Anti-Human Cytokeratin 7 Monoclonal Antibody (CBP2462)

Name: iNeuMab™ Rat Anti-Human Cytokeratin 7 Monoclonal Antibody (CBP2462)
SKU: NAB2010564LS
Rating: 5 (1 reviews)

[CAT#: NAB2010564LS]

Anti-Cytokeratin 7 Monoclonal Antibody

Host Species:: Rat

Species Reactivity:: Human

Applications:: WB; ICC

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Request Pricing

Inquiry

Product Overview

Immunogen

Human KRT7 peptide (446-462) conjugated to KLH.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Rat

Isotype

IgG2a, κ

Clone Number

CBP2462

Applications

WB; ICC

Relevant Diseases

Brain Tumors; Alzheimer's Disease; Parkinson's Disease; Neurocutaneous Syndromes

Research Areas

Neuroinflammation

Conjugation

Unconjugated; APC; PE; HRP; Biotin; FITC

Product Properties

Form

Liquid

Formulation

PBS, pH 7.2, containing 0.09% sodium azide.

Concentration

Batch Dependent

Purification

Affinity chromatography

Purity

>95%, as determined by Coomassie stained SDS-PAGE.

Endotoxin Level

Low Endotoxin

Shipping

The product is shipped at 4°C. Upon receipt, store it immediately at the recommended temperature.

Storage

Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody.

Handling Advice

Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody.

Research Use Only

For research use only, not for diagnostic or therapeutic use.

Target

Cytokeratin 7

Official Name

Cytokeratin 7

Full Name

Cytokeratin 7

Alternative Names

Keratin type II cytoskeletal 7; Cytokeratin-7; CK-7; Keratin-7; K7; Type-II keratin Kb7; Sarcolectin; SCL; Cytokeratin 7; Keratin 7

References

1. Tajima Y, et al. 2017. Sci Rep. 7:40684.
2. Huang B, et al. 2016. Oncogene. 35:4927.
3. Szponar A, et al. 2012. Virchows Arch. 460:423.
4. Sano M, et al. 2010. Int J Oncol. 36:321.

Publications